Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Co-op admits to blocking rivals from opening nearby stores

(Sharecast News) - The Competition and Markets Authority said on Wednesday that the Co-op has admitted to 107 breaches of an order put in place to stop the blocking of rivals from opening nearby stores. The watchdog found that the supermarket chain, which owns almost 2,400 stores across the UK, breached the Groceries Market Investigation (Controlled Land) Order 2010.

The order was introduced to stop supermarkets imposing restrictions that block rivals from opening competing stores nearby.

"By ensuring supermarkets compete freely, the CMA is ensuring that shoppers have more choice and so benefit from a wider range of groceries and access to cheaper prices," it said.

The CMA said it was concerned that this "substantial" number of breaches shows a significant failure of compliance for a business of Co-op's size.

Having already addressed 104 agreements, Co-op has also agreed to resolve the remaining three.

Daniel Turnbull, senior director of markets at the CMA, said: "Restrictive agreements by our leading retailers affect competition between supermarkets and impact shoppers trying to get the best deals.

"We know that Co-op has made a considerable effort to amend all their unlawful agreements, given this order has been in place since 2010. Co-op and the other designated retailers must make sure they do the right thing by their customers in the future."

The Co-op holds a 5.2% market share in the UK's £190.9bn supermarket industry.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.